A 92.6% reduction in the list price of tafamidis—an effective but ultimately unaffordable drug designed to treat transthyretin amyloid cardiomyopathy—would be required to make the medication accessible to the average heart patient, researchers reported in Circulation Feb. 12.

“This pioneering effort leverages evidence-based guidelines and the consensus of medical experts in a new and powerful way to optimize care for military veterans,” said Theodore L. DeWeese, MD, chair of ASTRO's board.

The Ad Hoc Group for Medical Research, which includes the American College of Radiology and Society of Nuclear Medicine and Molecular Imaging, is pushing for a bump to the institute's budget.

Tenet Healthcare Corporation and its affiliated Palm Springs, Calif., hospital Desert Regional Medical Center (DRMC) have agreed to pay $1.41 million to the U.S. government to settle False Claims Act allegations that the organization knowingly charged Medicare for unnecessary procedures.

A New York appeals court revived a lawsuit Feb. 11 involving a cardiologist who was accused of failing to diagnose a patient’s fatal kidney cancer nearly a decade and a half ago.

University of Michigan researchers recently made this discovery in a new analysis of commercial claims data, highlighted Tuesday in JAMA.

Radiology Imaging Associates in Englewood, Colorado, revealed Monday that its absorbing Denver-based competitor Rocky Mountain Radiologists and its two-dozen team members. 

The Heart Rhythm Society and Elsevier have partnered to launch the Cardiovascular Digital Health Journal, a peer-review, open-access publication that will debut in July.